These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 19854637)

  • 21. Complementary antineoplastic activity of the cytosine nucleoside analogues troxacitabine (Troxatyl) and cytarabine in human leukemia cells.
    Bouffard DY; Jolivet J; Leblond L; Hamelin B; Ouellet F; Barbeau S; Richard A; Gourdeau H
    Cancer Chemother Pharmacol; 2003 Dec; 52(6):497-506. PubMed ID: 12955470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of the optimal combination chemotherapy regimen for treatment of platinum-resistant ovarian cancer in nude mouse model.
    Saucier JM; Yu J; Gaikwad A; Coleman RL; Wolf JK; Smith JA
    J Oncol Pharm Pract; 2007 Mar; 13(1):39-45. PubMed ID: 17621566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. mTOR inhibition sensitizes gastric cancer to alkylating chemotherapy in vivo.
    Cejka D; Preusser M; Fuereder T; Sieghart W; Werzowa J; Strommer S; Wacheck V
    Anticancer Res; 2008; 28(6A):3801-8. PubMed ID: 19189667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy.
    Pietras K; Rubin K; Sjöblom T; Buchdunger E; Sjöquist M; Heldin CH; Ostman A
    Cancer Res; 2002 Oct; 62(19):5476-84. PubMed ID: 12359756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of combined administration of DPD-inhibitory oral fluoropyrimidine, S-1, plus paclitaxel on gene expressions of fluoropyrimidine metabolism-related enzymes in human gastric xenografts.
    Sakurai Y; Yoshida I; Kamoshida S; Inaba K; Isogaki J; Komori Y; Uyama I; Tsutsumi Y
    Ann Surg Oncol; 2008 Aug; 15(8):2301-9. PubMed ID: 18506536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ifosfamide-based drug combinations: preclinical evaluation of drug interactions and translation into the clinic.
    Vanhoefer U; Schleucher N; Klaassen U; Seeber S; Harstrick A
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):8-13. PubMed ID: 10697038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo characterization of a combination chemotherapy formulation consisting of vinorelbine and phosphatidylserine.
    Webb MS; Johnstone S; Morris TJ; Kennedy A; Gallagher R; Harasym N; Harasym T; Shew CR; Tardi P; Dragowska WH; Mayer LD; Bally MB
    Eur J Pharm Biopharm; 2007 Mar; 65(3):289-99. PubMed ID: 17123800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergy of irofulven in combination with other DNA damaging agents: synergistic interaction with altretamine, alkylating, and platinum-derived agents in the MV522 lung tumor model.
    Kelner MJ; McMorris TC; Rojas RJ; Estes LA; Suthipinijtham P
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):19-26. PubMed ID: 18305940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A minimal model of tumor growth inhibition in combination regimens under the hypothesis of no interaction between drugs.
    Magni P; Terranova N; Del Bene F; Germani M; De Nicolao G
    IEEE Trans Biomed Eng; 2012 Aug; 59(8):2161-70. PubMed ID: 22575633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction index and different methods for determining drug interaction in combination therapy.
    Lee JJ; Kong M; Ayers GD; Lotan R
    J Biopharm Stat; 2007; 17(3):461-80. PubMed ID: 17479394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modelling of tumour growth and cytotoxic effect of docetaxel in xenografts.
    Evans ND; Dimelow RJ; Yates JW
    Comput Methods Programs Biomed; 2014 May; 114(3):e3-13. PubMed ID: 23948442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel method for assessing in vitro oncology drug combinations using growth rates.
    Pashkevich M; Iversen P; Brooks H
    J Biopharm Stat; 2012; 22(3):496-518. PubMed ID: 22416837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Array of translational systems pharmacodynamic models of anti-cancer drugs.
    Ait-Oudhia S; Mager DE
    J Pharmacokinet Pharmacodyn; 2016 Dec; 43(6):549-565. PubMed ID: 27771815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modeling tumor growth inhibition and toxicity outcome after administration of anticancer agents in xenograft mice: A Dynamic Energy Budget (DEB) approach.
    Terranova N; Tosca EM; Borella E; Pesenti E; Rocchetti M; Magni P
    J Theor Biol; 2018 Aug; 450():1-14. PubMed ID: 29680449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A model-based approach for assessing in vivo combination therapy interactions.
    Lopez AM; Pegram MD; Slamon DJ; Landaw EM
    Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13023-8. PubMed ID: 10557266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A generalized response surface model with varying relative potency for assessing drug interaction.
    Kong M; Lee JJ
    Biometrics; 2006 Dec; 62(4):986-95. PubMed ID: 17156272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic-pharmacodynamic guided trial design in oncology.
    van Kesteren Ch; Mathôt RA; Beijnen JH; Schellens JH
    Invest New Drugs; 2003 May; 21(2):225-41. PubMed ID: 12889741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy.
    Palmer AC; Sorger PK
    Cell; 2017 Dec; 171(7):1678-1691.e13. PubMed ID: 29245013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing interactions for fixed-dose drug combinations in subcutaneous tumor xenograft studies.
    Wu J
    Pharm Stat; 2013; 12(3):115-9. PubMed ID: 23471653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation and translation of combination therapies in oncology - A quantitative approach.
    Cardilin T; Almquist J; Jirstrand M; Gabrielsson J
    Eur J Pharmacol; 2018 Sep; 834():327-336. PubMed ID: 30036534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.